Clinical trial

Hypothalamic GLP-1 Response in Healthy Weight and Obesity

NCT07854886

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-10-01

PhaseNA

Study timeline

Study start (estimated)2026-10-01Date precision: day

Registry last updated2026-10-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Normal Weightunresolved

Glucose Intoleranceunresolved

Interventions

Gastric glucoseOTHER

GLP-1(7-36)NH2OTHER

Exendin(9-39)NH2OTHER

Isoglycemic intravenous glucose infusionOTHER

Sponsors & collaborators

University of Copenhagenlead sponsor

Copenhagen University Hospital, Rigshospitaletcollaborator

Mapped research locations

CopenhagenDenmark1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07854886 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.